Kliniska studier för Amyloidos i New York
10 studier för Amyloidos söker deltagare vid platser i New York.
Städer i New York
Officiell studietext (engelska)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- Icahn School of Medicine at Mt. Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Manhasset
- Research Site, New York
- Research Site, New York
- och 1 fler
RekryterarObservationsstudie
Ålder 18 till 130 · Alla kön · Uppdaterad 23 sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Manhasset
- Clinical Trial Site, New York
- Clinical Trial Site, New York
- och 2 fler
RekryterarFas 3
Ålder 18 till 85 · Alla kön · Uppdaterad 16 sep. 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, New York
- Clinical Trial Site, New York
RekryterarFas 3
Ålder 18 till 85 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07223203ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, New York
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 8 sep. 2026 · NCT04561518Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
- Columbia University Medical Center, New York
RekryterarObservationsstudie
Ålder 30 till 80 · Alla kön · Uppdaterad 31 aug. 2026 · NCT05489549Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- New York University (NYU) School of Medicine - Langone Medical Center, New York
- Mount Sinai Hospital, New York
- Columbia University Medical Center, New York
- och 1 fler
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 4 aug. 2026 · NCT06563895A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, New York
- Research Site, New York
- Research Site, New York
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 juli 2026 · NCT07081646A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Icahn School of Medicine at Mount Sinai /ID# 255408, New York
- Columbia University Medical Center /ID# 255068, New York
- Memorial Sloan Kettering Cancer Center-Koch Center /ID# 255073, New York
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 maj 2026 · NCT06158854MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- New York University (NYU) School of Medicine - Langone Medical Center, New York
- Columbia University Medical Center, New York
RekryterarFas 3
Ålder 18 till 90 · Alla kön · Uppdaterad 27 mars 2026 · NCT06128629Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.